Description

Sherwin-Williams Walks Away From AkzoNobel — Capital Discipline Wins!

The Sherwin-Williams Company reported solid growth in its second quarter of 2026 despite an environment characterized by ongoing global uncertainty and lack of meaningful demand improvement. Consolidated sales increased by a high-single-digit percentage, including a low-single-digit contribution from the Suvinil acquisition. Gross margin slightly decreased on a reported basis but rose when excluding the Suvinil acquisition’s dilutive impact. The company implemented targeted pricing actions to mitigate raw material inflation. Selling, general and administrative (SG&A) expenses rose by a mid-single-digit percentage reported, primarily due to acquisition-related costs and higher employee expenses, but declined as a percentage of sales. Adjusted diluted net income per share improved approximately 10%, with adjusted EBITDA growing 10.5% to $1.5 billion, and margin expanded by 60 basis points to 21.5% of sales. Net operating cash improved 21%, and free cash flow conversion stood at 86%. Sherwin-Williams returned $1.